Condition
Chronic Radiation Proctitis
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Recruiting1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06837597Phase 3Not Yet RecruitingPrimary
Jianzhong Qushi in Chronic RRI
NCT06438809Phase 1RecruitingPrimary
Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis
NCT04680195Phase 2UnknownPrimary
Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable Bleeding
NCT03397901Not ApplicableUnknownPrimary
Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis: a Prospective Cohort Study
NCT01613534Phase 4CompletedPrimary
Combined Therapy in Radiation Proctopathy
Showing all 5 trials